Valens GroWorks Corp. (CSE:VGW) (TSXV:VGW) (OTC:VGWCF) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing, is pleased to announce it has substantially increased its annual extraction capacity to 425,000KG of dried cannabis and hemp biomass. As the largest third-party extraction company in Canada, Valens continues to experience significant demand for its services and are accelerating its growth to ensure the Company continues to meet the growing demand of its partners for both extraction and white label product development.


“We are excited to announce this significant advancement in our annual extraction capacity as we make room for more demand from our partners,” said Tyler Robson, CEO of Valens GroWorks. “This increase in scale together with our unique and comprehensive offering of CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction methodologies as well as our consumer product development and manufacturing capabilities position us to be the partner of choice for leading cannabis brands both in Canada and internationally.”

Jeffrey Fallows, President of Valens GroWorks, commented, “Our highly-customized infrastructure leverages a variety of extraction technologies from around the world, placing us at the cutting edge of the industry and uniquely positioning us to provide next generation products to our partners.”

Valens is also pleased to announce that construction has commenced on its recently acquired adjoining facility in Kelowna, British Columbia. This purpose-built facility will significantly increase the Company’s footprint and is anticipated to be completed in H1 2020 bringing Valens’ extraction capacity to over 1,000,000KG per annum. This new facility will also expand Valens’ white label capacity including capsules, vaporizers, topicals, edibles and concentrates.

Mr. Robson commented, “We are ramping up our white label product development activities as edibles and concentrates are expected to hit shelves later this year. With over 100 years of combined extraction experience on our team, we have worked hard on our formulation portfolio which will be essential to the development of new innovative products coming this year, enabling our partners to differentiate their offerings. While we continue to operate as a best-in-class provider of crude oil, winterized oil, distillate, and isolate to the cannabis market, our new capacity will also allow us to expand our capabilities in product development and manufacturing to meet changing consumer market demands.

“As the cannabis market evolves, we expect to see the creation of entirely new categories of cannabis-based products driven by a greater understanding of the potential uses of cannabis. Already, we are seeing an expanded portfolio of cannabis-based products emerging in the consumer packaged goods (CPG) industry, ranging from beverages to cosmetics, skincare items, and beyond. Our modern extraction technology and unrivalled expertise uniquely positions us to capitalize on this opportunity. Our capacity increase will advance this strategy to expand into the CPG category,” concluded Mr. Robson.

About Valens GroWorks

Valens GroWorks Corp. (CSE: VGW) (TSXV:VGW) (OTC: VGWCF) is a multi-licensed, vertically-integrated cannabis company focussed on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white label product development.  Valens is the largest third-party extraction Company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant.  Additionally, our subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science.  For more information, please visit http://valensgroworks.com.  The Company’s investor deck can be found specifically at http://valensgroworks.com/investors/

Notice regarding Forward Looking Statements

This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

Click here to connect with Valens GroWorks Corp (CSE:VGW, TSXV:VGW, OTC:MYMSF) for an Investor Presentation.

Source: www.prnewswire.com

Cannabis research firm New Frontier Data has released a new report in which it projects that the value of the total cannabis industry will reach US$51 billion by the year 2025.

Also this week, a few cannabis companies announced new international ventures. This side of the space is full of potential, but is relatively new compared to markets like the US and Canada.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“the Company”) today announced that it has officially launched its new cold storage services for 3rd party manufacturers with the onboarding of its first client, Kase Manufacturing (‘Kase’).

Kase will rent portions of TransCanna‘s 4,400 square foot, state-of-the-art cold storage cannabis freezer for specialized storage of Kase’s fresh-frozen cannabis biomass. The sub-40 degree Fahrenheit cannabis freezer, roughly the size of a five bedroom house, is the largest of its kind in Northern California.

Keep reading... Show less

Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”), an established Canadian cannabis and vape retailer, is pleased to announce that further to its press release dated August 26, 2021, all of its issued and outstanding common shares (the “Common Shares”) will begin trading on a post-consolidation basis on September 17, 2021 at the commencement of trading on the TSX Venture Exchange (“TSXV”).

On August 26, 2021, the Company announced that the Common Shares would be consolidated on the basis of one (1) post-consolidation Common Share for each five (5) pre-consolidation Common Shares (the “Share Consolidation“).

Keep reading... Show less

 TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it has received pre-qualification approval for cultivation, processing and retail licenses from the state of Michigan’s Marijuana Regulatory Agency pursuant to the Medical Marihuana Facilities Licensing Act. The pre-qualification approval represents TerrAscend’s successful completion of the most comprehensive portion of the State’s licensing and regulatory approval process. The pre-qualification approval is a key closing condition for TerrAscend’s previously announced acquisition of Gage Growth Corp.(“Gage”) (the “Transaction”). The Transaction will close as soon as possible after receipt of the applicable shareholder, court and other regulatory approvals and satisfaction or waiver of all other conditions in the definitive arrangement agreement (the “Arrangement Agreement”).

Keep reading... Show less

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce it has increased the size of its previously announced non-brokered private placement from USD $2,000,000 to over USD $2,500,000 (the “Private Placement”). This increase is designed to accommodate additional demand that the Company has received in the financing.

Keep reading... Show less